A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome

Seminars in Cancer Biology

Volumn 20, Issue 4, 2010, Pages 211-221

  Konkel, Miriam K ^a   Batzer, Mark A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Cancer; Genome instability; Non allelic homologous recombination; Retrotransposon; Transposable element

Indexed keywords

ALU SEQUENCE; CANCER CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE REARRANGEMENT; GENETIC DISORDER; GENETIC STABILITY; GENETIC VARIABILITY; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; LONG INTERSPERSED REPEAT; MALIGNANT NEOPLASTIC DISEASE; MUTAGENESIS; RETROPOSON; REVIEW; SHORT INTERSPERSED REPEAT; SOMATIC CELL; TRANSPOSON; VARIABLE NUMBER OF TANDEM REPEAT;

DNA BREAKS, DOUBLE-STRANDED; DNA METHYLATION; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; RETROELEMENTS; TERMINAL REPEAT SEQUENCES;

EID: 77956858478     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2010.03.001     Document Type: Review

References (152)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
2. Conrad D.F., Pinto D., Redon R., Feuk L., Gokcumen O., Zhang Y., et al. Origins and functional impact of copy number variation in the human genome. Nature 2009.
3. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
4. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
5. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
6. Kidd J.M., Cooper G.M., Donahue W.F., Hayden H.S., Sampas N., Graves T., et al. Mapping and sequencing of structural variation from eight human genomes. Nature 2008, 453:56-64.
7. Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution. Nat Rev Genet 2009, 10:691-703.
8. Smit A.F. The origin of interspersed repeats in the human genome. Curr Opin Genet Dev 1996, 6:743-748.
9. Smit A.F., Toth G., Riggs A.D., Jurka J. Ancestral, mammalian-wide subfamilies of LINE-1 repetitive sequences. J Mol Biol 1995, 246:401-417.
10. Hedges D.J., Deininger P.L. Inviting instability: transposable elements, double-strand breaks, and the maintenance of genome integrity. Mutat Res 2007, 616:46-59.
11. Xing J., Zhang Y., Han K., Salem A.H., Sen S.K., Huff C.D., et al. Mobile elements create structural variation: analysis of a complete human genome. Genome Res 2009, 19:1516-1526.
12. Belancio V.P., Hedges D.J., Deininger P. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 2008, 18:343-358.
13. Callinan P.A., Batzer M.A. Retrotransposable elements and human disease. Genome Dyn 2006, 1:104-115.
14. Chen J.M., Stenson P.D., Cooper D.N., Ferec C. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 2005, 117:411-427.
15. Batzer M.A., Deininger P.L. Alu repeats and human genomic diversity. Nat Rev Genet 2002, 3:370-379.
16. Deininger P.L., Batzer M.A. Alu repeats and human disease. Mol Genet Metab 1999, 67:183-193.
17. Goodier J.L., Kazazian H.H. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
18. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
19. Pace J.K., 2nd, Feschotte C. The evolutionary history of human DNA transposons: evidence for intense activity in the primate lineage. Genome Res 2007, 17:422-432.
20. Ostertag E.M., Kazazian H.H. Biology of mammalian L1 retrotransposons. Annu Rev Genet 2001, 35:501-538.
21. Mills R.E., Bennett E.A., Iskow R.C., Devine S.E. Which transposable elements are active in the human genome?. Trends Genet 2007, 23:183-191.
22. Kurth R., Bannert N. Beneficial and detrimental effects of human endogenous retroviruses. Int J Cancer 2010, 126:306-314.
23. Bennett E.A., Keller H., Mills R.E., Schmidt S., Moran J.V., Weichenrieder O., et al. Active Alu retrotransposons in the human genome. Genome Res 2008, 18:1875-1883.
24. Babushok D.V., Kazazian H.H. Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat 2007, 28:527-539.
25. Skowronski J., Fanning T.G., Singer M.F. Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol 1988, 8:1385-1397.
26. Martin S.L., Branciforte D., Keller D., Bain D.L. Trimeric structure for an essential protein in L1 retrotransposition. Proc Natl Acad Sci USA 2003, 100:13815-13820.
27. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
28. Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA 1997, 94:1872-1877.
29. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
30. Brouha B., Schustak J., Badge R.M., Lutz-Prigge S., Farley A.H., Moran J.V., et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 2003, 100:5280-5285.
31. Dewannieux M., Esnault C., Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 2003, 35:41-48.
32. Wei W., Gilbert N., Ooi S.L., Lawler J.F., Ostertag E.M., Kazazian H.H., et al. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 2001, 21:1429-1439.
33. Weiner A.M., Deininger P.L., Efstratiadis A. Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information. Annu Rev Biochem 1986, 55:631-661.
34. Roy-Engel A.M., Batzer M.A., Deininger P. Evolution of human retrosequences: Alu. Encyclopedia of life sciences 2008, John Wiley & Sons, Ltd. H. Kehrer-Sawatzki (Ed.).
35. Ostertag E.M., Goodier J.L., Zhang Y., Kazazian H.H. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet 2003, 73:1444-1451.
36. Wang H., Xing J., Grover D., Hedges D.J., Han K., Walker J.A., et al. SVA elements: a hominid-specific retroposon family. J Mol Biol 2005, 354:994-1007.
37. Damert A., Raiz J., Horn A.V., Lower J., Wang H., Xing J., et al. 5'-Transducing SVA retrotransposon groups spread efficiently throughout the human genome. Genome Res 2009, 19:1992-2008.
38. Cost G.J., Feng Q., Jacquier A., Boeke J.D. Human L1 element target-primed reverse transcription in vitro. EMBO J 2002, 21:5899-5910.
39. Luan D.D., Eickbush T.H. RNA template requirements for target DNA-primed reverse transcription by the R2 retrotransposable element. Mol Cell Biol 1995, 15:3882-3891.
40. Cost G.J., Boeke J.D. Targeting of human retrotransposon integration is directed by the specificity of the L1 endonuclease for regions of unusual DNA structure. Biochemistry 1998, 37:18081-18093.
41. Symer D.E., Connelly C., Szak S.T., Caputo E.M., Cost G.J., Parmigiani G., et al. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 2002, 110:327-338.
42. Beauregard A., Curcio M.J., Belfort M. The take and give between retrotransposable elements and their hosts. Annu Rev Genet 2008, 42:587-617.
43. Gasior S.L., Wakeman T.P., Xu B., Deininger P.L. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 2006, 357:1383-1393.
44. Gilbert N., Lutz S., Morrish T.A., Moran J.V. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol 2005, 25:7780-7795.
45. Ichiyanagi K., Nakajima R., Kajikawa M., Okada N. Novel retrotransposon analysis reveals multiple mobility pathways dictated by hosts. Genome Res 2007, 17:33-41.
46. Zingler N., Willhoeft U., Brose H.P., Schoder V., Jahns T., Hanschmann K.M., et al. Analysis of 5' junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5'-end attachment requiring microhomology-mediated end-joining. Genome Res 2005, 15:780-789.
47. Suzuki J., Yamaguchi K., Kajikawa M., Ichiyanagi K., Adachi N., Koyama H., et al. Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition. PLoS Genet 2009, 5:e1000461.
48. Szak S.T., Pickeral O.K., Makalowski W., Boguski M.S., Landsman D., Boeke J.D. Molecular archeology of L1 insertions in the human genome. Genome Biol 2002, 3. research0052.1-research0052.18.
49. Coufal N.G., Garcia-Perez J.L., Peng G.E., Yeo G.W., Mu Y., Lovci M.T., et al. L1 retrotransposition in human neural progenitor cells. Nature 2009, 460:1127-1131.
50. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005, 435:903-910.
51. Kano H., Godoy I., Courtney C., Vetter M.R., Gerton G.L., Ostertag E.M., et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev 2009, 23:1303-1312.
52. van den Hurk J.A., Meij I.C., Seleme M.C., Kano H., Nikopoulos K., Hoefsloot L.H., et al. L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet 2007, 16:1587-1592.
53. Cordaux R., Lee J., Dinoso L., Batzer M.A. Recently integrated Alu retrotransposons are essentially neutral residents of the human genome. Gene 2006, 373:138-144.
54. Ovchinnikov I., Troxel A.B., Swergold G.D. Genomic characterization of recent human LINE-1 insertions: evidence supporting random insertion. Genome Res 2001, 11:2050-2058.
55. Myers J.S., Vincent B.J., Udall H., Watkins W.S., Morrish T.A., Kilroy G.E., et al. A comprehensive analysis of recently integrated human Ta L1 elements. Am J Hum Genet 2002, 71:312-326.
56. van de Lagemaat L.N., Gagnier L., Medstrand P., Mager D.L. Genomic deletions and precise removal of transposable elements mediated by short identical DNA segments in primates. Genome Res 2005, 15:1243-1249.
57. Ray D.A., Xing J., Salem A.H., Batzer M.A. SINEs of a nearly perfect character. Syst Biol 2006, 55:928-935.
58. Belancio V.P., Deininger P.L., Roy-Engel A.M. LINE dancing in the human genome: transposable elements and disease. Genome Med 2009, 1:97.
59. Belancio V.P., Roy-Engel A.M., Deininger P. The impact of multiple splice sites in human L1 elements. Gene 2008, 411:38-45.
60. Han J.S., Boeke J.D. LINE-1 retrotransposons: modulators of quantity and quality of mammalian gene expression?. Bioessays 2005, 27:775-784.
61. Perepelitsa-Belancio V., Deininger P. RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat Genet 2003, 35:363-366.
62. Chen J.M., Ferec C., Cooper D.N. LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease: mutation detection bias and multiple mechanisms of target gene disruption. J Biomed Biotechnol 2006, 2006. 9 pp., Article ID 56182, doi:10.1155/JBB/2006/56182.
63. Sobczak K., Krzyzosiak W.J. Structural determinants of BRCA1 translational regulation. J Biol Chem 2002, 277:17349-17358.
64. Landry J.R., Medstrand P., Mager D.L. Repetitive elements in the 5' untranslated region of a human zinc-finger gene modulate transcription and translation efficiency. Genomics 2001, 76:110-116.
65. Chen L.L., Carmichael G.G. Gene regulation by SINES and inosines: biological consequences of A-to-I editing of Alu element inverted repeats. Cell Cycle 2008, 7:3294-3301.
66. Hasler J., Samuelsson T., Strub K. Useful 'junk': Alu RNAs in the human transcriptome. Cell Mol Life Sci 2007, 64:1793-1800.
67. Graham T., Boissinot S. The genomic distribution of L1 elements: the role of insertion bias and natural selection. J Biomed Biotechnol 2006, 2006. 5 pp., Article ID 75327, doi:10.1155/JBB/2006/75327.
68. Miki Y., Katagiri T., Kasumi F., Yoshimoto T., Nakamura Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 1996, 13:245-247.
69. Teugels E., De Brakeleer S., Goelen G., Lissens W., Sermijn E., De Greve J. De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes. Hum Mutat 2005, 26:284.
70. El-Sawy M., Deininger P. Tandem insertions of Alu elements. Cytogenet Genome Res 2005, 108:58-62.
71. Peixoto A., Santos C., Rocha P., Pinheiro M., Principe S., Pereira D., et al. The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. Breast Cancer Res Treat 2009, 114:31-38.
72. Ergun S., Buschmann C., Heukeshoven J., Dammann K., Schnieders F., Lauke H., et al. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem 2004, 279:27753-27763.
73. Kubo S., Seleme M.C., Soifer H.S., Perez J.L., Moran J.V., Kazazian H.H., et al. L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci USA 2006, 103:8036-8041.
74. Shi X., Seluanov A., Gorbunova V. Cell divisions are required for L1 retrotransposition. Mol Cell Biol 2007, 27:1264-1270.
75. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003, 10:431-442.
76. Belgnaoui S.M., Gosden R.G., Semmes O.J., Haoudi A. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int 2006, 6:13.
77. Gilbert N., Lutz-Prigge S., Moran J.V. Genomic deletions created upon LINE-1 retrotransposition. Cell 2002, 110:315-325.
78. Morrish T.A., Gilbert N., Myers J.S., Vincent B.J., Stamato T.D., Taccioli G.E., et al. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet 2002, 31:159-165.
79. Callinan P.A., Wang J., Herke S.W., Garber R.K., Liang P., Batzer M.A. Alu retrotransposition-mediated deletion. J Mol Biol 2005, 348:791-800.
80. Han K., Sen S.K., Wang J., Callinan P.A., Lee J., Cordaux R., et al. Genomic rearrangements by LINE-1 insertion-mediated deletion in the human and chimpanzee lineages. Nucleic Acids Res 2005, 33:4040-4052.
81. Sen S.K., Huang C.T., Han K., Batzer M.A. Endonuclease-independent insertion provides an alternative pathway for L1 retrotransposition in the human genome. Nucleic Acids Res 2007, 35:3741-3751.
82. Srikanta D., Sen S.K., Huang C.T., Conlin E.M., Rhodes R.M., Batzer M.A. An alternative pathway for Alu retrotransposition suggests a role in DNA double-strand break repair. Genomics 2009, 93:205-212.
83. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., et al. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol Cell 2004, 14:611-623.
84. Su L.K., Steinbach G., Sawyer J.C., Hindi M., Ward P.A., Lynch P.M. Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis. Hum Genet 2000, 106:101-107.
85. Shen M.R., Batzer M.A., Deininger P.L. Evolution of the master Alu gene(s). J Mol Evol 1991, 33:311-320.
86. Lobachev K.S., Stenger J.E., Kozyreva O.G., Jurka J., Gordenin D.A., Resnick M.A. Inverted Alu repeats unstable in yeast are excluded from the human genome. EMBO J 2000, 19:3822-3830.
87. Stenger J.E., Lobachev K.S., Gordenin D., Darden T.A., Jurka J., Resnick M.A. Biased distribution of inverted and direct Alus in the human genome: implications for insertion, exclusion, and genome stability. Genome Res 2001, 11:12-27.
88. Voineagu I., Narayanan V., Lobachev K.S., Mirkin S.M. Replication stalling at unstable inverted repeats: interplay between DNA hairpins and fork stabilizing proteins. Proc Natl Acad Sci USA 2008, 105:9936-9941.
89. van Gent D.C., Hoeijmakers J.H., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2001, 2:196-206.
90. Kennedy R.D., D'Andrea A.D. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 2006, 24:3799-3808.
91. Luo G., Santoro I.M., McDaniel L.D., Nishijima I., Mills M., Youssoufian H., et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 2000, 26:424-429.
92. Gu W., Zhang F., Lupski J.R. Mechanisms for human genomic rearrangements. Pathogenetics 2008, 1:4.
93. Sen S.K., Han K., Wang J., Lee J., Wang H., Callinan P.A., et al. Human genomic deletions mediated by recombination between Alu elements. Am J Hum Genet 2006, 79:41-53.
94. Han K., Lee J., Meyer T.J., Remedios P., Goodwin L., Batzer M.A. L1 recombination-associated deletions generate human genomic variation. Proc Natl Acad Sci USA 2008, 105:19366-19371.
95. Lee J., Han K., Meyer T.J., Kim H.S., Batzer M.A. Chromosomal inversions between human and chimpanzee lineages caused by retrotransposons. PLoS One 2008, 3:e4047.
96. Kolomietz E., Meyn M.S., Pandita A., Squire J.A. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 2002, 35:97-112.
97. Onno M., Nakamura T., Hillova J., Hill M. Rearrangement of the human tre oncogene by homologous recombination between Alu repeats of nucleotide sequences from two different chromosomes. Oncogene 1992, 7:2519-2523.
98. Elliott B., Richardson C., Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol Cell 2005, 17:885-894.
99. Weinstock D.M., Richardson C.A., Elliott B., Jasin M. Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair (Amst) 2006, 5:1065-1074.
100. Lupski J.R. Genomic rearrangements and sporadic disease. Nat Genet 2007, 39:S43-S47.
101. Bruder C.E., Piotrowski A., Gijsbers A.A., Andersson R., Erickson S., de Stahl T.D., et al. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 2008, 82:763-771.
102. Franke G., Bausch B., Hoffmann M.M., Cybulla M., Wilhelm C., Kohlhase J., et al. Alu-Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 2009, 30:776-786.
103. Schichman S.A., Caligiuri M.A., Strout M.P., Carter S.L., Gu Y., Canaani E., et al. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 1994, 54:4277-4280.
104. Strout M.P., Marcucci G., Bloomfield C.D., Caligiuri M.A. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci USA 1998, 95:2390-2395.
105. Walsh T., Casadei S., Coats K.H., Swisher E., Stray S.M., Higgins J., et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 2006, 295:1379-1388.
106. Han K., Lee J., Meyer T.J., Wang J., Sen S.K., Srikanta D., et al. Alu recombination-mediated structural deletions in the chimpanzee genome. PLoS Genet 2007, 3:1939-1949.
107. Bailey J.A., Liu G., Eichler E.E. An Alu transposition model for the origin and expansion of human segmental duplications. Am J Hum Genet 2003, 73:823-834.
108. Oliveira C., Senz J., Kaurah P., Pinheiro H., Sanges R., Haegert A., et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009, 18:1545-1555.
109. Oliveira C., Seruca R., Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006, 14:21-33.
110. Graeser M.K., Engel C., Rhiem K., Gadzicki D., Bick U., Kast K., et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2009, 27:5887-5892.
111. Li L., McVety S., Younan R., Liang P., Du Sart D., Gordon P.H., et al. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 2006, 27:388.
112. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005, 25:415-422.
113. Armaou S., Konstantopoulou I., Anagnostopoulos T., Razis E., Boukovinas I., Xenidis N., et al. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. Eur J Cancer 2007, 43:443-453.
114. Mitchell R.J., Farrington S.M., Dunlop M.G., Campbell H. Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002, 156:885-902.
115. Witherspoon D.J., Watkins W.S., Zhang Y., Xing J., Tolpinrud W.L., Hedges D.J., et al. Alu repeats increase local recombination rates. BMC Genomics 2009, 10:530.
116. Petrij-Bosch A., Peelen T., van Vliet M., van Eijk R., Olmer R., Drusedau M., et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997, 17:341-345.
117. Caligiuri M.A., Strout M.P., Schichman S.A., Mrozek K., Arthur D.C., Herzig G.P., et al. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 1996, 56:1418-1425.
118. O'Neil J., Tchinda J., Gutierrez A., Moreau L., Maser R.S., Wong K.K., et al. Alu elements mediate MYB gene tandem duplication in human T-ALL. J Exp Med 2007, 204:3059-3066.
119. Schnittger S., Wormann B., Hiddemann W., Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998, 92:1728-1734.
120. Whitman S.P., Liu S., Vukosavljevic T., Rush L.J., Yu L., Liu C., et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood 2005, 106:345-352.
121. Wilson A.S., Power B.E., Molloy P.L. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007, 1775:138-162.
122. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
123. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., et al. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
124. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., San Jose-Eneriz E., et al. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk Res 2008, 32:487-490.
125. Daskalos A., Nikolaidis G., Xinarianos G., Savvari P., Cassidy A., Zakopoulou R., et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009, 124:81-87.
126. Suter C.M., Martin D.I., Ward R.L. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 2004, 19:95-101.
127. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 1997, 13:335-340.
128. Florl A.R., Lower R., Schmitz-Drager B.J., Schulz W.A. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 1999, 80:1312-1321.
129. Lin C.H., Hsieh S.Y., Sheen I.S., Lee W.C., Chen T.C., Shyu W.C., et al. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 2001, 61:4238-4243.
130. Bourc'his D., Bestor T.H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004, 431:96-99.
131. Howard G., Eiges R., Gaudet F., Jaenisch R., Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008, 27:404-408.
132. Miki Y., Nishisho I., Horii A., Miyoshi Y., Utsunomiya J., Kinzler K.W., et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992, 52:643-645.
133. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 2001, 21:1973-1985.
134. Cruickshanks H.A., Tufarelli C. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics 2009, 94:397-406.
135. Halling K.C., Lazzaro C.R., Honchel R., Bufill J.A., Powell S.M., Arndt C.A., et al. Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene. Hum Hered 1999, 49:97-102.
136. Economou-Pachnis A., Tsichlis P.N. Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus. Nucleic Acids Res 1985, 13:8379-8387.
137. Wallace M.R., Andersen L.B., Saulino A.M., Gregory P.E., Glover T.W., Collins F.S. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991, 353:864-866.
138. Casarin A., Martella M., Polli R., Leonardi E., Anesi L., Murgia A. Molecular characterization of large deletions in the von Hippel-Lindau (VHL) gene by quantitative real-time PCR: the hypothesis of an alu-mediated mechanism underlying VHL gene rearrangements. Mol Diagn Ther 2006, 10:243-249.
139. Tournier I., Paillerets B.B., Sobol H., Stoppa-Lyonnet D., Lidereau R., Barrois M., et al. Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 2004, 64:8143-8147.
140. Cybulski C., Wokolorczyk D., Huzarski T., Byrski T., Gronwald J., Gorski B., et al. A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet 2006, 43:863-866.
141. Charbonnier F., Olschwang S., Wang Q., Boisson C., Martin C., Buisine M.P., et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002, 62:848-853.
142. van der Klift H., Wijnen J., Wagner A., Verkuilen P., Tops C., Otway R., et al. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 2005, 44:123-138.
143. Pistorius S., Gorgens H., Plaschke J., Hoehl R., Kruger S., Engel C., et al. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 2007, 248:89-95.
144. Aissi-Ben Moussa S., Moussa A., Lovecchio T., Kourda N., Najjar T., Ben Jilani S., et al. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination. Fam Cancer 2009, 8:119-126.
145. Thiffault I., Hamel N., Pal T., McVety S., Marcus V.A., Farber D., et al. Germline truncating mutations in both MSH2 and BRCA2 in a single kindred. Br J Cancer 2004, 90:483-491.
146. Wagner A., Barrows A., Wijnen J.T., van der Klift H., Franken P.F., Verkuijlen P., et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003, 72:1088-1100.
147. Froggatt N.J., Joyce J.A., Evans D.G., Lunt P.W., Koch D.J., Ponder B.J., et al. MSH2 sequence variations and inherited colorectal cancer susceptibility. Eur J Cancer 1996, 32A:178.
148. Fukuuchi A., Nagamura Y., Yaguchi H., Ohkura N., Obara T., Tsukada T. A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol 2006, 36:739-744.
149. Rothberg P.G., Ponnuru S., Baker D., Bradley J.F., Freeman A.I., Cibis G.W., et al. A deletion polymorphism due to Alu-Alu recombination in intron 2 of the retinoblastoma gene: association with human gliomas. Mol Carcinog 1997, 19:69-73.
150. Hsieh S.Y., Chen W.Y., Yeh T.S., Sheen I.S., Huang S.F. High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene 2005, 24:6584-6589.
151. Gervasini C., Venturin M., Orzan F., Friso A., Clementi M., Tenconi R., et al. Uncommon Alu-mediated NF1 microdeletion with a breakpoint inside the NF1 gene. Genomics 2005, 85:273-279.
152. Yap K.P., Ang P., Lim I.H., Ho G.H., Lee A.S. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing. Clin Genet 2006, 70:80-82.